IRMA-International.org: Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

Cancer Biomarker Assessment Using Evolutionary Rough Multi-Objective Optimization Algorithm

Cancer Biomarker Assessment Using Evolutionary Rough Multi-Objective Optimization Algorithm
View Sample PDF
Author(s): Anasua Sarkar (Government College of Engineering and Leather Technology, India)and Ujjwal Maulik (Jadavpur University, India)
Copyright: 2015
Pages: 27
Source title: Handbook of Research on Artificial Intelligence Techniques and Algorithms
Source Author(s)/Editor(s): Pandian Vasant (University of Technology Petronas, Malaysia)
DOI: 10.4018/978-1-4666-7258-1.ch016

Purchase

View Cancer Biomarker Assessment Using Evolutionary Rough Multi-Objective Optimization Algorithm on the publisher's website for pricing and purchasing information.

Abstract

A hybrid unsupervised learning algorithm, which is termed as Evolutionary Rough Multi-Objective Optimization (ERMOO) algorithm, is proposed in this chapter. It comprises a judicious integration of the principles of the rough sets theory with the archived multi-objective simulated annealing approach. While the concept of boundary approximations of rough sets in this implementation deals with the incompleteness in the dynamic classification method with the quality of classification coefficient as the classificatory competence measurement, it enables faster convergence of the Pareto-archived evolution strategy. It incorporates both the rough set-based dynamic archive classification method in this algorithm. A measure of the amount of domination between two solutions is incorporated in this chapter to determine the acceptance probability of a new solution with an improvement in the spread of the non-dominated solutions in the Pareto-front by adopting rough sets theory. The performance is demonstrated on real-life breast cancer dataset for identification of Cancer Associated Fibroblasts (CAFs) within the tumor stroma, and the identified biomarkers are reported. Moreover, biological significance tests are carried out for the obtained markers.

Related Content

Kamel Mouloudj, Vu Lan Oanh LE, Achouak Bouarar, Ahmed Chemseddine Bouarar, Dachel Martínez Asanza, Mayuri Srivastava. © 2024. 20 pages.
José Eduardo Aleixo, José Luís Reis, Sandrina Francisca Teixeira, Ana Pinto de Lima. © 2024. 52 pages.
Jorge Figueiredo, Isabel Oliveira, Sérgio Silva, Margarida Pocinho, António Cardoso, Manuel Pereira. © 2024. 24 pages.
Fatih Pinarbasi. © 2024. 20 pages.
Stavros Kaperonis. © 2024. 25 pages.
Thomas Rui Mendes, Ana Cristina Antunes. © 2024. 24 pages.
Nuno Geada. © 2024. 12 pages.
Body Bottom